A Study of YPEG-rhEPO in Patients Suffered From Anemia Due to Chronic Kidney Disease

NCT04885647 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Anemia of Chronic Kidney Disease

Interventions

DRUG: YPEG-rhEPO
DRUG: YPEG-rhEPO
DRUG: YPEG-rhEPO
DRUG: YPEG-rhEPO

Sponsor

Xiamen Amoytop Biotech Co., Ltd.

Collaborators

[object Object]